Señales en vivo de AXLA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 dic 2023 @ 15:59):

Stats
Volumen de hoy	6 782.00
Volumen promedio	54 521.00
Capitalización de mercado	1.18M
EPS	$0 ( 2024-03-28 )
Próxima fecha de ganancias	( $0 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0220
ATR14	$0.625 (155.90%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Koziel Margaret	Sell	679	Common Stock
2023-02-17	Koziel Margaret	Buy	70 000	Stock Option (Right to Buy)
2023-02-17	Hinshaw William	Buy	275 000	Stock Option (Right to Buy)
2023-02-17	Fehlner Paul	Buy	70 000	Stock Option (Right to Buy)
2023-02-10	Fehlner Paul	Buy	5 221	Common Stock

INSIDER POWER
99.86
Last 92 transactions
Buy: 44 458 855 \| Sell: 477 523

Volumen Correlación

Largo: 0.47 (neutral)

Corto: 0.41 (neutral)

Signal:(20.847) Neutral

Axcella Health Inc Correlación

10 Correlaciones Más Positivas
SEED	0.947
DZSI	0.941
POTX	0.94
INO	0.937
VIVE	0.933
RKDA	0.927
CHB	0.926
KRKR	0.926
PRPO	0.925
AQB	0.925

10 Correlaciones Más Negativas
MPRA	-0.943
NCAC	-0.941
APXI	-0.936
VMGA	-0.93
SCRM	-0.927
ALSA	-0.927
ZING	-0.926
TRON	-0.926
ARTEU	-0.924
ADAL	-0.921

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Axcella Health Inc Correlación - Moneda/Commodity

-0.64
( weak negative )

-0.47
( neutral )

0.53
( weak )

-0.30
( neutral )

0.43
( neutral )

Axcella Health Inc Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-1.520

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-1.520

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.700

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.780

Financial Reports:

No articles found.

Axcella Health Inc

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Actualizaciones en tiempo real para Axcella Health Inc [AXLA]

Upcoming Earnings Alert